These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8053452)

  • 41. [Prevention of gastroduodenal disorders with the use of non-steroidal anti-inflammatory drugs].
    Bijlsma JW; van Berge Henegouwen GP; de Boer SY; Dijkmans BA; Festen HP; Janssen M
    Ned Tijdschr Geneeskd; 1991 Jan; 135(2):45-8. PubMed ID: 1990306
    [No Abstract]   [Full Text] [Related]  

  • 42. Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.
    Simon LS; Hatoum HT; Bittman RM; Archambault WT; Polisson RP
    Fam Med; 1996 Mar; 28(3):204-10. PubMed ID: 8900554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [How to reduce the risks of NSAIDs].
    Gross M
    MMW Fortschr Med; 2008 Jul; 150(28-31):50-3; quiz 54. PubMed ID: 19006892
    [No Abstract]   [Full Text] [Related]  

  • 44. Misoprostol and NSAID ulcers.
    Isaacs P
    Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480
    [No Abstract]   [Full Text] [Related]  

  • 45. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Chan FK; Sung JJ
    N Engl J Med; 1998 Jul; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
    [No Abstract]   [Full Text] [Related]  

  • 47. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Scheiman JM
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonsteroidal anti-inflammatory drug use in dentistry: gastrointestinal implications.
    Nguyen AM; Graham DY; Gage T; Griffiths GR
    Gen Dent; 1999; 47(6):590-6; quiz 597-8. PubMed ID: 10687453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [High-risk patients taking NSAIDs are threatened with dangerous complications].
    Infirm Aux; 1989; 61(4):17. PubMed ID: 2722232
    [No Abstract]   [Full Text] [Related]  

  • 53. [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
    MMW Fortschr Med; 2004 Mar; 146(13):61. PubMed ID: 15219139
    [No Abstract]   [Full Text] [Related]  

  • 54. Arthrotec for all?
    Cullen D; Hawkey CJ
    Ann Rheum Dis; 1993 Dec; 52(12):841-2. PubMed ID: 8311531
    [No Abstract]   [Full Text] [Related]  

  • 55. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
    J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Healing and prevention of NSAID-associated ulcer disease: is seeing believing?
    Fendrick AM; Scheiman JM
    Am J Gastroenterol; 1998 Dec; 93(12):2628-9. PubMed ID: 9860450
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A
    Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of gastrointestinal damage induced by nonsalicylate nonsteroidal antiinflammatory drugs.
    Florent C; Mazieres B; Gordin J
    Rev Rhum Engl Ed; 1996 Feb; 63(2):131-4. PubMed ID: 8689284
    [No Abstract]   [Full Text] [Related]  

  • 59. Prophylaxis against non-steroidal induced upper gastrointestinal side effects.
    Barrison I
    Ann Rheum Dis; 1991 Apr; 50(4):207-9. PubMed ID: 1903030
    [No Abstract]   [Full Text] [Related]  

  • 60. Misoprostol for co-prescription with NSAIDs.
    Drug Ther Bull; 1990 Apr; 28(7):25-6. PubMed ID: 2131244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.